Nancy Ann Deparle Cvs Health Corp (CVS) insider trading activity

Nancy Ann Deparle is Director of CVS HEALTH Corp. Currently has a direct ownership of 34,169 shares of CVS, which is worth approximately $1.52 Million. The most recent transaction as insider was on Nov 21, 2024, when has been sold 2,331 shares (Common Stock) at a price of $57.1 per share, resulting in proceeds of $133,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.2K

7.32% 3M change

15.73% 12M change

Total Value Held $1.52 Million

NANCY ANN DEPARLE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 21 2024	BUY Grant, award, or other acquisition	$133,100 $57.1 p/Share	2,331 Added 6.39%	34,169 Common Stock
May 16 2024	BUY Grant, award, or other acquisition	$133,101 $57.52 p/Share	2,314 Added 6.78%	31,838 Common Stock
Nov 15 2023	BUY Grant, award, or other acquisition	$133,075 $69.13 p/Share	1,925 Added 6.12%	29,524 Common Stock
May 18 2023	BUY Grant, award, or other acquisition	$99,598 $69.31 p/Share	1,437 Added 4.95%	27,599 Common Stock
Nov 17 2022	BUY Grant, award, or other acquisition	$133,091 $94.93 p/Share	1,402 Added 5.09%	26,162 Common Stock
May 11 2022	BUY Grant, award, or other acquisition	$133,070 $97.99 p/Share	1,358 Added 5.2%	24,760 Common Stock
Nov 17 2021	BUY Grant, award, or other acquisition	$123,702 $92.73 p/Share	1,334 Added 5.39%	23,402 Common Stock
May 13 2021	BUY Grant, award, or other acquisition	$123,708 $84.27 p/Share	1,468 Added 6.24%	22,068 Common Stock
Nov 18 2020	BUY Grant, award, or other acquisition	$121,819 $66.35 p/Share	1,836 Added 8.18%	20,600 Common Stock
May 14 2020	BUY Grant, award, or other acquisition	$121,816 $62.31 p/Share	1,955 Added 9.44%	18,764 Common Stock
Nov 20 2019	BUY Grant, award, or other acquisition	$121,820 $74.92 p/Share	1,626 Added 9.05%	16,339 Common Stock
May 16 2019	BUY Grant, award, or other acquisition	$121,859 $52.3 p/Share	2,330 Added 13.67%	14,713 Common Stock
Nov 07 2018	BUY Grant, award, or other acquisition	$104,922 $78.77 p/Share	1,332 Added 9.71%	12,383 Common Stock
Jun 04 2018	BUY Grant, award, or other acquisition	$104,996 $64.1 p/Share	1,638 Added 12.91%	11,051 Common Stock
Nov 08 2017	BUY Grant, award, or other acquisition	$104,934 $68.99 p/Share	1,521 Added 13.91%	9,413 Common Stock
May 10 2017	BUY Grant, award, or other acquisition	$104,979 $80.94 p/Share	1,297 Added 14.11%	7,892 Common Stock
Nov 02 2016	BUY Grant, award, or other acquisition	$104,937 $83.95 p/Share	1,250 Added 15.93%	6,595 Common Stock
May 19 2016	BUY Grant, award, or other acquisition	$104,988 $100.95 p/Share	1,040 Added 16.29%	5,345 Common Stock
Nov 04 2015	BUY Grant, award, or other acquisition	$83,938 $99.57 p/Share	843 Added 16.38%	4,305 Common Stock
May 07 2015	BUY Grant, award, or other acquisition	$83,959 $99.36 p/Share	845 Added 19.62%	3,462 Common Stock
Nov 05 2014	BUY Grant, award, or other acquisition	$52,500 $87.5 p/Share	600 Added 18.65%	2,617 Common Stock
May 08 2014	BUY Grant, award, or other acquisition	$52,495 $75.86 p/Share	692 Added 25.54%	2,017 Common Stock

Also insider at

HCA

HCA Healthcare, Inc. Healthcare

Director

NAD